Warning letter
John Balbian: warning letter of Dec 31, 2013
FDA warning letter 415555 · New York District Office
Key facts
| Reference number | 415555 |
|---|---|
| Company | John Balbian |
| Subject | Illegal Drug Residue |
| Issue date | Dec 31, 2013 |
| Posted date | Dec 31, 2013 |
| Issuing office | New York District Office |
| Product type | Veterinary |
| CFR sections cited | 530, 556.430, 530.11(a), 530.11(b), 530.3(a), 530.11(c) |
| Inspection city | Amsterdam |
| Inspection ZIP | 12010 |
| Inspection start date | Sep 10, 2013 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- VAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: